Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 20,000 shares at $60.05 ($622K) on 2021-09-03, disclosed to the SEC on 2021-09-03.
Open-market sale of $622k KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 10,000 | $21K | 3.3% |
| 2 | $60.05 | 8,500 | $510K | 82.1% |
| 3 | $60.50 | 1,500 | $91K | 14.6% |
| Total | $31.10 avg | 20,000 | $622K | 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |